LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ready-to-Use Control Determines Linearity for Special Diabetes Tests

By LabMedica International staff writers
Posted on 13 Apr 2015
The new, ready-to-use “Linearity LQ Special Diabetes,” an assayed quality-control material consisting of 5 distinct levels that demonstrate a linear relationship to each other when assayed for C-peptide, fructosamine, and insulin
The new, ready-to-use “Linearity LQ Special Diabetes,” an assayed quality-control material consisting of 5 distinct levels that demonstrate a linear relationship to each other when assayed for C-peptide, fructosamine, and insulin (Photo courtesy of AUDIT MICROCONTROLS)
A new addition to clinical lab quality control products simulates human patient serum samples for the purpose of determining linearity, calibration verification, and verification of reportable range for special diabetes tests.

The Linearity LQ Special Diabetes from AUDIT MicroControls, Inc. (Eatonton, GA, USA) is an assayed quality-control material consisting of 5 distinct levels that demonstrate a linear relationship to each other when assayed for C-peptide, fructosamine, and insulin. It is a ready-to-use liquid product with open vial stability of 7 days when stored at 2–8 °C.

AUDIT MicroControls provides “Auditor QC,” a free on-line, real-time data reduction program that offers Levey-Jennings charts and peer group analysis for daily quality control product users, as well as linearity graphs and peer group analysis. Report results are given immediately in an inspector friendly format and stored on the Auditor QC website for convenient future reference.

AUDIT is a total solution in daily quality controls and calibration verification materials, providing high-quality products, easy-to-use data management tools, and personalized service. Synergistic partnership with leading manufacturer and supplier Aalto Scientific enables AUDIT to offer significant cost savings and a broad line of superior solutions that address challenges faced by today’s clinical labs.

Related Links:

AUDIT MicroControls
Linearity LQ Special Diabetes


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more